Verona Pharma Plc (VRP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
57
About the Report
About the Report
Summary
Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilator/anti-inflammatory drug which is being developed for a wide range of indications including chronic obstructive pulmonary disease (COPD), cystic fibrosis and asthma. The company has collaborations with King's College London McGill University and The University of North Carolina for conducting research and experimental studies and to the fund exploratory studies. It has operations across North America and the UK. Verona Pharma is headquartered in London, the UK.
Verona Pharma Plc (VRP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Verona Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verona Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verona Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Verona Pharma Enters into Agreement with European Technology Companies 11
Equity Offering 12
Verona Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 12
Verona Pharma Raises USD78 Million in Public Offering of Shares 13
Verona Pharma Announces Exercise of Over-Allotment Option for Public Offering of ADS for USD87.2 Million 14
Verona Pharma Raises USD2 Million in Private Placement of Shares 16
Verona Pharma Raises USD63 Million in Private Placement of Units 18
Verona Pharma Raises USD21.7 Million in Private Placement of Shares 21
Verona Pharma Completes Rights Offering Of Shares For USD 1.7 Million 22
Verona Pharma Announces Private Placement Of Shares For USD 1.3 Million 23
Verona Pharma Prices Private Placement Of Shares For USD 2 Million 24
Verona Pharma Announces Private Placement Of Shares For USD 8 Million 25
Verona Pharma Plc-Key Competitors 26
Verona Pharma Plc-Key Employees 27
Verona Pharma Plc-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Nov 06, 2018: Verona Pharma: Operational update and financial results for the three and nine months ended September 30, 2018 29
Aug 07, 2018: Verona Pharma: Operational update and financial results for the three and six months ended June 30, 2018 36
May 08, 2018: Verona Pharma Operational Update and Financial Results for the First Quarter Ended March 31, 2018 37
Feb 27, 2018: Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017 41
Nov 07, 2017: Verona Pharma Operational Update and Financial Results for the Third Quarter Ended September 30, 2017 48
Aug 08, 2017: Verona Pharma Interim Results for the Six Months Ended June 30, 2017 50
Feb 27, 2017: Verona Pharma Announces Financial results for the year ended 31 December 2016 51
Corporate Communications 53
Apr 11, 2018: Verona Pharma Announces Departure of Chief Medical Officer 53
Apr 03, 2017: Verona Pharma announces new collaborations to develop dry powder and MDI formulations for COPD 54
Apr 03, 2017: Verona Pharma Announces Board Change 55
Mar 31, 2017: Verona Pharma appoints commercial director 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
List of Figure
List of Figures
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verona Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Verona Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verona Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verona Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Verona Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Verona Pharma Enters into Agreement with European Technology Companies 11
Verona Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 12
Verona Pharma Raises USD78 Million in Public Offering of Shares 13
Verona Pharma Announces Exercise of Over-Allotment Option for Public Offering of ADS for USD87.2 Million 14
Verona Pharma Raises USD2 Million in Private Placement of Shares 16
Verona Pharma Raises USD63 Million in Private Placement of Units 18
Verona Pharma Raises USD21.7 Million in Private Placement of Shares 21
Verona Pharma Completes Rights Offering Of Shares For USD 1.7 Million 22
Verona Pharma Announces Private Placement Of Shares For USD 1.3 Million 23
Verona Pharma Prices Private Placement Of Shares For USD 2 Million 24
Verona Pharma Announces Private Placement Of Shares For USD 8 Million 25
Verona Pharma Plc, Key Competitors 26
Verona Pharma Plc, Key Employees 27
Verona Pharma Plc, Subsidiaries 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.